HARVARD BIOSCIENCE INC — Investor Relations & Filings

Harvard Bioscience is a global developer, manufacturer, and marketer of technologies, products, and services for the life science research and drug discovery markets. The company provides a broad range of specialized scientific instruments, systems, software, and consumables that support fundamental research, preclinical studies, production, and safety compliance. Key product areas include instrumentation for electrophysiology, such as patch clamp amplifiers and multi-electrode array (MEA) systems; preclinical monitoring systems for physiological data like glucose levels, temperature, and activity in animal models; and spectrophotometry instruments for quality control applications. The company also offers specialized software, including the Ponemah® platform, for data acquisition and analysis, with capabilities for GLP and 21 CFR part 11 compliance. Its solutions are designed to enable the discovery, safety, and production of new therapeutics.